MYD88 and neoplasm: Treatment of MyD88-deficient mice carrying B16.F1 tumors with attenuated Salmonella was ineffective in regressing tumor growth, indicating that bacterial therapy of tumors is dependent on TLR-MyD88 signaling (23).